-
News
- Technology /AI
- Medical journals
- Topics
Medical News
Efficacy of Luspatercept in 1st Line Treatment of Anemia Due to Low-Risk Myelodysplastic Syndrome
24. 5. 2024 Source: Myelodysplastic Syndrome (MDS)A planned interim analysis of the COMMANDS study showed a greater benefit of the innovative treatment with luspatercept compared to the established treatment with epoetin alfa in patients with anemia due to low-risk myelodysplastic syndrome (MDS) and untreated with erythropoiesis-stimulating agents (ESA). The results were published in June 2023 in the journal Lancet.
HPD 2024: Czech data from real-world practice confirm that mucolytic treatment can reduce COPD exacerbations, even in the future
Chronic obstructive pulmonary disease (COPD) is a global issue. Does it create the same burden everywhere? How does it contribute to premature deaths? How do women cope with COPD, and what…24. 5. 2024 Source: Cough Therapy
HPD 2024: Bronchitis as an Early Feature of PreCOPD, Role of Mucus Plugs in COPD, and New Findings on Their Exacerbations
Exacerbations of chronic obstructive pulmonary disease (COPD) significantly affect disease progression, quality of life, survival, and cardiovascular events. What to do about them and how to address…24. 5. 2024 Source: Cough Therapy
Benefit of Oral Semaglutide for Patients with Type 2 Diabetes in the General Practitioner's Office
Oral semaglutide is a modern antidiabetic suitable within primary care for people with type 2 diabetes, primarily due to its comprehensive action that includes not only reducing blood glucose and body...22. 5. 2024 Source: Modern Treatment of Diabetes with GLP-1 Analogues
Targeting HER2 is Clinically Meaningful Even with Its Low Expression
Distinguishing HER2 receptor expression status on the surface of breast cancer tumor cells as simply positive or negative is now proving insufficient. Ultimately, it can lead to the…22. 5. 2024 Source: Ovarian and Breast Cancer
A device the size of a matchbox will help treat obstructive sleep apnea
Obstructive sleep apnea, also known as sleep apnea syndrome, is the second most common sleep disorder in the world. It affects up to one billion people worldwide between the ages of 30 and 69.…21. 5. 2024 Source: medScope.pro
Current Recommendations of the International League Against Epilepsy for the Treatment of Seizures in Newborns
In 2023, a team of experts in neurology, neonatology, and pediatrics, along with representatives of parents, published recommendations for the treatment of epileptic seizures in newborns. These were…21. 5. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
Epilepsy with Generalized Tonic-Clonic Seizures in an Adolescent Patient – A Case Study
This is the story of Anička, a 16-year-old girl who has been treated for epilepsy since she was 14. Her condition is accompanied by generalized tonic-clonic seizures, which may need to be managed…21. 5. 2024 Source: Quick aid for acute convulsive seizures in children and adolescents
INFOGRAPHIC: Mavacamten in the treatment of obstructive hypertrophic cardiomyopathy
Obstructive hypertrophic cardiomyopathy (HCM) is most commonly caused by disorders of cardiac muscle proteins. How does targeted treatment for this disease work? We bring a concise, graphically processed...17. 5. 2024 Source: Hypertrophic Cardiomyopathy (HCM)
CASE STUDY: Key Benefits of GLP-1RA in Diabetes Therapy in the Office of a General Practitioner
Modern therapy using glucagon-like peptide-1 receptor agonists (GLP-1RA) offers diabetics highly effective management of their primary condition as well as several other advantages: it reduces the risk...16. 5. 2024 Source: Modern Treatment of Diabetes with GLP-1 Analogues
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Technology /AI